Adicet Bio, Inc. Accrued Liabilities, Current
Adicet Bio, Inc. (ACET) had Accrued Liabilities, Current of $1.10 million as of 2020-06-30, per its 10-Q filed 2020-07-30.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2020-07-30
- 2020-06-30: Accrued Liabilities, Current $1.10M.
- 2020-03-31: Accrued Liabilities, Current $1.35M.
- 2019-12-31: Accrued Liabilities, Current $5.48M.
- 2019-09-30: Accrued Liabilities, Current $2.22M.
| Period end | Accrued Liabilities, Current |
|---|---|
| 2020-06-30 | $1.10M 10-Q · filed 2020-07-30 |
| 2020-03-31 | $1.35M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $5.48M 10-Q · filed 2020-07-30 |
| 2019-09-30 | $2.22M 10-Q · filed 2019-11-05 |
| 2019-06-30 | $1.46M 10-Q · filed 2019-08-14 |
| 2019-03-31 | $1.25M 10-Q · filed 2019-05-15 |
| 2018-12-31 | $2.73M 10-K · filed 2020-03-12 |
| 2018-09-30 | $3.36M 10-Q · filed 2018-11-13 |
| 2018-06-30 | $6.57M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $4.85M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $3.99M 10-K · filed 2019-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |